Millions deprived of life-saving antifungal medicines

0 comment(s)

The world is in the grip of a global crisis that kills the equivalent of the populations of Philadelphia, Kampala or Prague, – around 1.6 million each year. A new report published today in the Journal of Antimicrobial Chemotherapy, documents how many countries do not have life-saving antifungal therapies. Professor David Denning of The University of Manchester & President of GAFFI and the paper’s lead author says it beggars believe that hundreds of millions of people cannot access the optimal therapy for fungal meningitis and fungal lung infections globally.

World's 1st CPA guidelines presented at European Respiratory Meeting

0 comment(s)

At the European Respiratory Society (ERS) Conference in Amsterdam the first world guidelines for chronic pulmonary aspergillosis (CPA) have been presented by Professor Denning of the National Aspergillosis Centre, Manchester, UK. The guidelines have been drawn up in conjunction the ERS and ESCMID and will be published in the European Respiratory Journal in October.

The guidelines describe the 5 clinical phenotypes of CPA and how to diagnose and manage these patients.